All Type of News
Health minister-nominee object to supermarkets’ selling drugs
Chin Soo-hee, nominee for health and welfare minister, said in her written statement on August 20 that she will not allow supermarkets to sell over-the-counter drugs, calling it "unprofessional and unacceptable, befor...
KFDA to strengthen standards for ginkgo biloba extract
The Korea Food and Drug Administration is considering accepting DAB–grade ginkgo biloba extracts for export and domestic use.
Currently, the drug agency has approved the USP based ginkgo biloba extracts, but the st...
Korean drugmakers urged to benchmark Scotland’s biotechnology business
Domestic pharmaceutical companies will have to model the biotechnology business in Scotland by exchanging the required technologies for sustained growth in a global arena, according to experts.
“This is a great opp...
Hanmi targets European market with Amosartan
Hanmi Pharm said on August 23 it is conducting a phase I clinical trial of Amosartan (amlodipine camsylate+losartan potassium), a hypertension combination drug in CCB + ARB class, to obtain an approval in EU.
Compa...
Daewoong enters agreement with Medivir for markeing rights to cold sore treatment Xerclear
Daewoong Pharm says it has signed an agreement with Swenden-based Medivir AB to distribute Medivir’s Xerclear (acyclovir and hydrocortisone) for non-prescription use (OTC) in Korea.
Xerclear is the first and only t...
Handok’s Amaryl M exposed to fierce competition
A blockbuster drug in Korea will not be as stable as before with a growing number of pharmaceutical companies poising to enter a 20 billion Amaryl M (glimepiride + metroformin HCl) market.
More than 20 pharmaceuti...
Hanmi spends 15% of revenue on R&D
Details of drug company spending revealed in the first half of this year show that a combined spending of the country's top pharmaceutical companies (29 companies listed in the Korean Exchange plus 17 companies listed...
Government to supply enough seasonal flu vaccines
Health officials said they will brace for a possible outbreak of influenza amid growing concern that infections could surge.
According to the Korea Food and Drug Administration, measures will be taken to have Korea...
Government urged to introduce two-way referral system in health insurance
It is generally assumed that health care systems in which specialist and hospital care is only accessible after referral by a general practitioner (GP) have lower total health care costs.
In a local seminar, Profes...
Whanin signs co-promotion agreement with Lundbeck Korea
Whanin Pharm says it has signed an agreement with Lundbeck Korea to co-promote and distribute nalmefene, an opioid receptor antagonist used primarily in the management of alcohol dependence, in Korea.
H. Lundbeck ...
